Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Nov 1;89(21):10557-61.
doi: 10.1073/pnas.89.21.10557.

Homozygous deletions within human chromosome band 9p21 in melanoma

Affiliations

Homozygous deletions within human chromosome band 9p21 in melanoma

J W Fountain et al. Proc Natl Acad Sci U S A. .

Abstract

Genetic studies have implicated the early involvement of a gene on chromosome arm 9p in the development of cutaneous melanoma. We have performed loss-of-heterozygosity studies to confirm these original findings and identify the most frequently rearranged or deleted region of 9p. Eight markers were analyzed, including (from 9pter to proximal 9q) D9S33, the beta-interferon (IFNB1) locus, the alpha-interferon (IFNA) gene cluster, D9S126, D9S3, D9S19, the glycoprotein 4 beta-galactosyltransferase (GGTB2) gene, and the argininosuccinate synthetase pseudogene 3 (ASSP3). Two or more of these loci were found to be hemizygously reduced in 12 of 14 (86%) informative metastatic melanoma tumor and cell line DNAs, and homozygous deletions of the marker D9S126 were observed in 2 of 20 (10%) melanoma cell lines. These findings have resulted in the identification of a small critical region of 2-3 megabases on 9p21 in which a putative melanoma tumor-suppressor gene appears likely to reside. Several 9p candidate genes, including IFNB1, the IFNA gene cluster, GGTB2, and the tyrosinase-related protein (TYRP) locus, have all been eliminated as potential targets because they are located outside of the homozygously deleted regions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Anticancer Res. 1990 Jul-Aug;10(4):859-71 - PubMed
    1. Leukemia. 1991 Aug;5(8):680-2 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4614-8 - PubMed
    1. Cancer Genet Cytogenet. 1989 Sep;41(2):185-201 - PubMed
    1. Cancer Res. 1987 Aug 1;47(15):3995-4000 - PubMed

Publication types

MeSH terms